CVS Health Corporation (NYSE: CVS) on Wednesday announced financial results for the fourth quarter of 2022, reporting a modest increase in adjusted
CVS Earnings: CVS Health Q4 2022 profit, revenue increase
Categories
retail pharmacy
AMGN Infographic: Amgen’s Q4 2022 profit drops on flat revenues
Amgen Inc. (NASDAQ: AMGN) said its revenues remained unchanged in the fourth quarter of 2022 when the biotechnology firm's earnings declined. Unadjusted
Should you buy CVS Health (CVS) stock before Q4 earnings?
CVS Health Corporation (NYSE: CVS), the largest retail pharmacy chain, is on a mission to make quality healthcare available to everyone. A
Walgreens Boots Alliance (WBA) Q1 2023 Earnings: Key financials and quarterly highlights
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) reported first quarter 2023 earnings results today. Sales decreased 1.5% year-over-year to $33.4 billion. Net loss
WBA Stock: Should you invest in Walgreens Boots Alliance ahead of earnings?
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) has been a key contributor to the COVID-19 vaccination campaign, supported by its extensive retail network.
CVS Health Corporation (CVS) Earnings: 3Q22 Key Numbers
CVS Health Corporation (NYSE: CVS) reported third quarter 2022 earnings results. Total revenues increased 10% year-over-year to $81.2 billion. Net loss attributable
Walgreens Boots Alliance (WBA) Q4 2022 Earnings: Key financials and quarterly highlights
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) reported fourth quarter 2022 earnings results today. Total sales amounted to $32.4 billion compared to $34.2 billion
Walgreens Boots Alliance (WBA) Q3 profit drops on lower revenues; results beat
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) on Thursday said its third-quarter revenues decreased. As a result, the healthcare service company's adjusted profit
Trxade (MEDS) is increasing the breadth of product offerings: CEO Suren Ajjarapu
Trxade Health Inc. (NASDAQ: MEDS) is an online pharmaceutical marketplace that provides a platform for independent pharmacies to operate more efficiently. The
CVS Health (CVS) is a great stock to buy this year. Here’s why
CVS Health Corporation (NYSE: CVS), a diversified health services company, made an impressive start to the year after ending 2021 on a
CVS Health Earnings Q1 2022: Here are the key highlights from the results
CVS Health (NYSE: CVS) reported first quarter 2022 earnings results today. Total revenues for the quarter increased to $76.8 billion, up 11.2%
Key highlights from Walgreens Boots Alliance (WBA) Q2 2022 earnings results
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) reported second quarter 2022 earnings results today. Sales increased 3% year-over-year to $33.8 billion. Sales growth
Sigma Healthcare Ltd (SIG) Q4 2021 Earnings Call Transcript
Sigma Healthcare Ltd ( ?????? : SIG) Q4 2021 earnings call dated Mar. 28, 2022 Corporate Participants: Vikesh Ramsunder -- Chief Executive Officer and
Trxade Health (MEDS) reports 20% growth in Q4 revenue; results beat estimates
Trxade Health Inc (NASDAQ: MEDS) Monday reported a narrower net loss for the fourth quarter of 2021 as the pharmaceutical services company's revenues
Walgreens Boots Alliance (WBA) Q1 Earnings: Key financials and quarterly highlights
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) reported first quarter 2022 earnings results today. Sales increased 7.8% year-over-year to $33.9 billion. Net earnings
Infographic: How CVS Health Corporation (CVS) performed in Q3 2021
CVS Health Corporation (NYSE: CVS) reported third quarter 2021 earnings results today. Total revenues increased 10% year-over-year to $73.8 billion. Net income
CVS Health Corp. (CVS) Earnings: 2Q21 Key Numbers
VS Health Corporation (NYSE: CVS) reported second-quarter 2021 earnings results today. Total revenues increased 11.1% to $72.6 billion compared to the same
Trxade CEO: Will see consistent margins ahead
Shares of Trxade Health Inc (NASDAQ: MEDS) took a beating post the second-quarter results earlier this week as the provider of integrated
Trxade Health adds 195 registered members in Q2
Trxade Health Inc (NASDAQ: MEDS) on Monday posted second-quarter revenues of $1.9 million, down year-over-over as a result of non-recurring PPE sales.
CVS Health gets a shot in the arm from COVID care: Is the stock a buy?
After being hit by the virus-induced slowdown in store footfall initially, CVS Health Corporation (NYSE: CVS) has regained the lost momentum by
Here’s a look at the pros and cons of investing in Cigna (CI)
After a series of ups and downs, shares of healthcare company Cigna Corporation (NYSE: CI) rose to a record high a few